Title: Colossal Biosciences Secures $200 Million for Revolutionary De-Extinction Venture
Colossal Biosciences, the trailblazing company behind, well, it's almost like a real-life "Jurassic Park" scenario, bringing back extinct bird and mammal species like the thylacine, dodo, and woolly mammoth, announced they secured an additional $200 million in funding through a Series C round led by TWG Global. This boosts their value to a staggering $10.2 billion, with a total investment of $435 million.
The funds will be used to further their genetic engineering technologies and pioneer revolutionary software, wetware, and hardware solutions. These innovations not only aid in de-extinction but also contribute to species preservation and human healthcare.
CEO and co-founder Ben Lamm stated, "Investors are eager to help us scale as rapidly as possible. This new capital will boost our team, fuel technology development, widen our de-extinction species list, and continue our mission to make extinction obsolete."
Operating labs in Dallas, Boston, and Melbourne, Colossal collaborates with research labs at 16 universities worldwide. Their team has already made significant strides, including helping to preserve the last northern white rhinoceros and funding research into preserving endangered Australian bird species.
TWG Global CEO Mark Walter praised Colossal as the "leading company at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation." The fusion of technology and conservation represents a core value for TWG Global.
With a diverse investor pool supporting their endeavors, Colossal is going from strength to strength. TWG Global, known for its interests in technology, AI, financial services, private lending, sports, and media, spearheaded the latest funding round.
Joining forces with Colossal are tech entrepreneurs, industry leaders, and Hollywood icons, such as George Church, Dr. Andrew Pask, Barney Long, USIT, Animal Capital, Breyer Capital, At One Ventures, In-Q-Tel, BOLD Capital, Peak 6, Draper Associates, Peter Jackson, Fran Walsh, and several others.
Their innovative work has captured the attention of governments and institutions, who seek collaborations in species preservation and backup through bio vaults. With their recent success and ambitious plans, it appears that Colossal Biosciences is blazing a trail in a fascinating and influential field.
The additional funding from TWG Global and other investors will allow Colossal Biosciences' CEO Mark Walter to expand their team, enhance technological advancements in de-extinction, and potentially bring back species like the thylacine and woolly mammoth through the company Colossal Biosciences, led by Ben Lamm, has already collaborated with global universities and saved the last northern white rhinoceros. Thomas Tull, representing TWG Global, commends Colossal as a leader in AI, computational biology, and genetic engineering for de-extinction and conservation.
